University home page

Find an ExpertProfiling the University of Melbourne's Researchers

DR IAN DAVIS



Contact Details

Organization: Medicine - Austin Health and Northern Health
Position: Honorary (Principal Fellow)
Email:

Government Research Classifications

Research Fields, Courses and Discipline Classifications

Socio-Economic Objective Classifications

Publications

Publications produced at the University of Melbourne and reported in the Annual Publications Collection and 'Research Report' since 2001. The Themis Publications module, released in November 2006, allows additional publications from previous institutions and publications from past years to be entered.

Publications in 2009

Journal Articles

  • O6-methylguanine-DNA methyltransferase depletion and DNA damage in patients with melanoma treated with temozolomide alone or with lomeguatrib
    Year: 2009
    Journal: British Journal of Cancer
    Volume: 100
    Issue: 8
    Page numbers: 1250-1256
    Author(s):
    Super Search Source this item in the University's Catalouge locate this resource.

  • An open-label, single-arm phase two trial of Gefitinib in patients with advanced or metastatic castration-resistant prostate cancer


    Year: 2009
    Journal: American Journal of Clinical Oncology - Cancer Clinical Trials
    Volume: 32
    Issue: 4
    Page numbers: 338-341
    Author(s):
    Super Search Source this item in the University's Catalouge locate this resource.

  • Cancer/testis antigens can be immunological targets in clonogenic CD133+ melanoma cells


    Year: 2009
    Journal: Cancer Immunology, Immunotherapy
    Volume: 58
    Issue: 10
    Page numbers: 1635-1646
    Author(s):
    Super Search Source this item in the University's Catalouge locate this resource.
  • A long, naturally presented immunodominant epitope from NY-ESO-1 tumor antigen:  Implications for cancer vaccine design
    Year: 2009
    Journal: Cancer Research
    Volume: 69
    Issue: 3
    Page numbers: 1046-1054
    Author(s):
    Super Search Source this item in the University's Catalouge locate this resource.
  • Clinical and biological efficacy of recombinant human interleukin-21 in patients with stage IV malignant melanoma without prior treatment:  A phase IIa trial
    Year: 2009
    Journal: Clinical Cancer Research
    Volume: 15
    Issue: 6
    Page numbers: 2123-2129
    Author(s):
    Super Search Source this item in the University's Catalouge locate this resource.
  • Melan-A-specific cytoxic T cells are associated with tumor regression and autoimmunity following treatment with anti-CTLA-4
    Year: 2009
    Journal: Clinical Cancer Research
    Volume: 15
    Issue: 7
    Page numbers: 2507-2513
    Author(s):
    Super Search Source this item in the University's Catalouge locate this resource.
  • Regulatory T-cell-mediated attenuation of T-cell responses to the NY-ESO-1 ISCOMATRIX vaccine in patients with advanced malignant melanoma
    Year: 2009
    Journal: Clinical Cancer Research
    Volume: 15
    Issue: 6
    Page numbers: 2166-2173
    Author(s):
    Super Search Source this item in the University's Catalouge locate this resource.
  • Therapeutic efficacy of 177Lu-CHX-A"-DTPA-hu3S193 radioimmunotherapy in prostate cancer is enhanced by EGFR inhibition or docetaxel chemotherapy
    Year: 2009
    Journal: The Prostate
    Volume: 69
    Page numbers: 92-104
    Author(s):
    Super Search Source this item in the University's Catalouge locate this resource.

Publications in 2008

Journal Articles

  • Clinical Use of Therapies Targeting Tumor Vasculature and Stroma.
    Year: 2008
    Journal: Current Cancer Drug Targets
    Volume: 8
    Issue: 6
    Page numbers: 498-508
    Author(s):
    Super Search Source this item in the University's Catalouge locate this resource.
  • ECSA/DPPA2 is an embryo-cancer antigen that is coexpressed with cancer-testis antigens in non-small cell lung cancer
    Year: 2008
    Journal: Clinical Cancer Research
    Volume: 14
    Issue: 11
    Page numbers: 3291-3298
    Author(s):
    Super Search Source this item in the University's Catalouge locate this resource.
  • IL-21 induces in vivo immune activation of NK cells and CD8+ T cells in patients with metastatic melanoma and renal cell carcinoma
    Year: 2008
    Journal: Cancer Immunology, Immunotherapy
    Volume: 57
    Page numbers: 1439-1449
    Author(s):
    Super Search Source this item in the University's Catalouge locate this resource.
  • Peripheral primitive neuroectodermal tumor arising from the seminal vesicle
    Year: 2008
    Journal: Urologia Internationalis
    Volume: 80
    Issue: 2
    Page numbers: 212-216
    Author(s):
    Super Search Source this item in the University's Catalouge locate this resource.
  • Predicting clinical outcome through molecular profiling in stage III melanoma
    Year: 2008
    Journal: Clinical Cancer Research
    Volume: 14
    Issue: 16
    Page numbers: 5173-5180
    Author(s):
    Super Search Source this item in the University's Catalouge locate this resource.
  • Targeted therapies in the treatment of renal cell carcinoma
    Year: 2008
    Journal: Current Medicinal Chemistry
    Volume: 15
    Page numbers: 1166-1174
    Author(s):
    Super Search Source this item in the University's Catalouge locate this resource.
  • The regulatory T cell-associated transcription factor FoxP3 is expressed by tumor cells
    Year: 2008
    Journal: Cancer Research
    Volume: 68
    Issue: 8
    Page numbers: 3001-3009
    Author(s):
    Super Search Source this item in the University's Catalouge locate this resource.
  • Thyrotoxicosis during sunitinib treatment for renal cell carcinoma
    Year: 2008
    Journal: Clinical Endocrinology
    Volume: 69
    Issue: 2008
    Page numbers: 6669-672
    Author(s):
    Super Search Source this item in the University's Catalouge locate this resource.

Publications in 2007

Journal Articles

  • Tumour lysis syndrome in a patient with renal-cell carcinoma treated with sunitinib malate


    Year: 2007
    Journal: The Lancet
    Volume: 369
    Issue: 9577
    Page numbers: 1923-1924
    Author(s):
    Super Search Source this item in the University's Catalouge locate this resource.
  • A phase I multiple dose, dose escalation study of cG250 monoclonal antibody in patients with advanced renal cell carcinoma
    Year: 2007
    Journal: Cancer Immunology, Immunotherapy
    Volume: 7
    Issue: 2007
    Page numbers: 7-13
    Author(s):
    Super Search Source this item in the University's Catalouge locate this resource.
  • An Open-Label, Two-Arm, Phase I Trial of Recombinant Human Interleukin-21 in Patients with Metastatic Melanoma
    Year: 2007
    Journal: Clinical Cancer Research
    Volume: 13
    Issue: 12
    Page numbers: 3630-3636
    Author(s):
    Super Search Source this item in the University's Catalouge locate this resource.
  • Diagnostic and therapeutic use of radioisotopes for bony disease in prostate cancer: Current practice
    Year: 2007
    Journal: International Journal of Urology
    Volume: 14
    Issue: 2
    Page numbers: 89-95
    Author(s):
    Super Search Source this item in the University's Catalouge locate this resource.
  • Fourier transform infrared imaging as a method for detection of HLA class I expression in melanoma without the use of antibody.
    Year: 2007
    Journal: Tissue Antigens
    Volume: 69
    Issue: SUPP 1
    Page numbers: 252-258
    Author(s):
    Super Search Source this item in the University's Catalouge locate this resource.
  • Phase II trial of anti-idiotypic p53 peptides (pentrys) plus granulocyte-macrophase colony-stimulating factor in patients with hormone-refractory prostate cancer
    Year: 2007
    Journal: Asia-Pacific Journal of Clinical Oncology
    Volume: 3
    Issue: 2007
    Page numbers: 148-155
    Author(s):
    Super Search Source this item in the University's Catalouge locate this resource.
  • Randomized trial of the combination of lomeguatrib and temozolomide compared with temozolomide alone in chemotherapy naive patients with metastatic cutaneous melanoma
    Year: 2007
    Journal: Journal of Clinical Oncology
    Volume: 25
    Issue: 18
    Page numbers: 2540-2545
    Author(s):
    Super Search Source this item in the University's Catalouge locate this resource.
  • Renal Cell Cancer and Positron Emission Tomography- an Evolving Diagnostic and Therapeutic Relationship
    Year: 2007
    Journal: Current Medical Imaging Reviews
    Volume: 3
    Issue: 1
    Page numbers: 18-26
    Author(s):
    Super Search Source this item in the University's Catalouge locate this resource.

Publications in 2006

Journal Articles

  • Directions in the immune targeting of cancer: Lessons learned from the cancer-testis Ag NY-ESO-1


    Year: 2006
    Journal: Immunology and Cell Biology
    Volume: 84
    Issue: 2006
    Page numbers: 303-317
    Author(s):
    Super Search Source this item in the University's Catalouge locate this resource.
  • A phase 1 and pharmacokinetic study of gemcitabine and oxaliplatin in patients with solid tumors
    Year: 2006
    Journal: Cancer Chemotherapy and Pharmacology
    Volume: 58
    Issue: 2006
    Page numbers: 157-164
    Author(s):
    Super Search Source this item in the University's Catalouge locate this resource.
  • Blood Dendritic Cells Generated With Flt3 Ligand and CD40 Ligand Prime CD8+ T Cells Efficiently in Cancer Patients
    Year: 2006
    Journal: Journal of Immunotherapy
    Volume: 29
    Issue: 2006
    Page numbers: 499-511
    Author(s):
    Super Search Source this item in the University's Catalouge locate this resource.
  • Desmoplastic melanoma: comparison of expression of differentiation antigens and cancer testis antigens
    Year: 2006
    Journal: Melanoma Research
    Volume: 16
    Issue: 2006
    Page numbers: 347-355
    Author(s):
    Super Search Source this item in the University's Catalouge locate this resource.
  • Palifermin Reduces the Incidence of Oral Mucositis in Patients With Metastatic Colorectal Cancer Treated With Fluorouracil-Based Chemotherapy
    Year: 2006
    Journal: BJU International
    Volume: 97
    Issue: 2006
    Page numbers: 916-922
    Author(s):
    Super Search Source this item in the University's Catalouge locate this resource.
  • Phase II study of vinflunine in patients with metastatic renal cell carcinoma
    Year: 2006
    Journal: Investigational New Drugs
    Volume: 10
    Issue: 2006
    Page numbers: 429-434
    Author(s):
    Super Search Source this item in the University's Catalouge locate this resource.
  • Positron emission tomography (PET), immuno-PET and radioimmunotherapy in renal cell carcinoma: a developing diagnostic and therapeutic relationship.
    Year: 2006
    Journal: BJU International
    Volume: 97
    Issue: 5
    Page numbers: 916-922
    Author(s):
    Super Search Source this item in the University's Catalouge locate this resource.
  • Positron emission tomography and molecular imaging of the prostate: an update
    Year: 2006
    Journal: BJU International
    Volume: 97
    Issue: 2006
    Page numbers: 923-931
    Author(s):
    Super Search Source this item in the University's Catalouge locate this resource.
  • Striking Immunodominance Hierarchy of Naturally Occurring CD8+ and CD4+ T Cell Responses to Tumor Antigen NY-ESO-s11
    Year: 2006
    Journal: Immunology
    Volume: 176
    Issue: 2006
    Page numbers: 5908-2917
    Author(s):
    Super Search Source this item in the University's Catalouge locate this resource.
  • Xenografting Tumour beneath the Renal Capsule Using Modern Surgical Equipment
    Year: 2006
    Journal: European Surgical Research
    Volume: 38
    Issue: 2006
    Page numbers: 340-346
    Author(s):
    Super Search Source this item in the University's Catalouge locate this resource.

Publications in 2005

Journal Articles

  • A phase 1 and pharmacokinetic study of gemcitabine and oxaliplatin in patients with solid tumors
    Year: 2005
    Journal: Cancer Chemotherapy and Pharmacology
    Volume: electronic
    Page numbers: 1-8
    Publisher: Springer Verlag(New York)
    Author(s):
    Super Search Source this item in the University's Catalouge locate this resource.
  • A randomized, double-blinded, placebo-controlled phase II trial of recombinant human leukemia inhibitory factor (rhuLIF, Emfilermin, AM424) to prevent chemotherapy-induced peripheral neuropathy
    Year: 2005
    Journal: Clinical Cancer Research
    Volume: 11
    Issue: march 1
    Page numbers: 1890-1898
    Publisher: American Association for Cancer Research(Alabama)
    Author(s):
    Super Search Source this item in the University's Catalouge locate this resource.
  • Assessing regional hypoxia in human renal tumours using 18F-Fluoromisonidazole [18F-FMISO] positron emission tomography.
    Year: 2005
    Journal: BJU International
    Volume: 96
    Page numbers: 540-546
    Author(s):
    Super Search Source this item in the University's Catalouge locate this resource.
  • Biochemotherapy for the treatment of metastatic melanoma: the experience of a tertiary oncology center
    Year: 2005
    Journal: Asia-Pacific Journal of Clinical Oncology
    Volume: 1
    Page numbers: 81-87
    Publisher: Blackwell Publishers
    Author(s):
    Super Search Source this item in the University's Catalouge locate this resource.
  • Can't cope with 'acopoa' - letters to the editor
    Year: 2005
    Journal: Internal Medicine Journal
    Volume: 35
    Page numbers: 1-1
    Publisher: Blackwell Science Asia(Carlton)
    Author(s):
    Super Search Source this item in the University's Catalouge locate this resource.
  • Characterization of antigen-specific CD8+ T lymphocyte responses in skin and peripherl blood following intradermal peptide vaccination
    Year: 2005
    Journal: Cancer Immunity
    Volume: 5
    Page numbers: 5-11
    Publisher: Academy of Cancer Immunology
    Author(s):
    Super Search Source this item in the University's Catalouge locate this resource.
  • Immunological effects of chimeric anti-GD3 monoclonal antibody KM871 in patients with metastatic melanoma
    Year: 2005
    Journal: Cancer Immunity
    Volume: 5
    Page numbers: 3-14
    Publisher: Academy of Cancer Immunology
    Author(s):
    Super Search Source this item in the University's Catalouge locate this resource.
  • Impact fo 2-Deoxy-2[F-18]Fluoro-D-Glucose positron emission tomography on the management of patients with advanced melanoma
    Year: 2005
    Journal: Neuroimage
    Volume: 23
    Issue: july
    Page numbers: 1-5
    Publisher: Academic Press(California)
    Author(s):
    Super Search Source this item in the University's Catalouge locate this resource.
  • Phase I Trial of 131I-huA33 in Patients with Advanced Colorectal Carcinoma
    Year: 2005
    Journal: Clinical Cancer Research
    Volume: 11
    Issue: 13
    Page numbers: 4818-4826
    Author(s):
    Super Search Source this item in the University's Catalouge locate this resource.
  • Recombinant NY-ESO-1 cancer antigen: Production and purification under cGMP conditions
    Year: 2005
    Journal: Preparative Biochemistry & Biotechnology
    Volume: 35
    Page numbers: 119-134
    Author(s):
    Super Search Source this item in the University's Catalouge locate this resource.
  • Tumor antigen processing and presentation depend critically on dendritic cell type and the mode of antigen delivery
    Year: 2005
    Journal: Blood
    Volume: 105
    Page numbers: 2465-2472
    Publisher: American Society of Hematology(Washington DC)
    Author(s):
    Super Search Source this item in the University's Catalouge locate this resource.
  • Ventricular metastasis resulting in disseminated intravascular coagulation
    Year: 2005
    Journal: World Journal of Surgical Oncology
    Volume: 3
    Page numbers: 29-32
    Publisher: Biomed Central(London)
    Author(s):
    Super Search Source this item in the University's Catalouge locate this resource.

Publications in 2004

Journal Articles

  • 18F-Fluorodeoxyglucose positron emission tomography in evaluation of germ cell tumor after chemotherapy
    Year: 2004
    Journal: Urology
    Volume: 64
    Page numbers: 1202-1207
    Publisher: Excerpta Medica(Philadelphia)
    Author(s):
    Super Search Source this item in the University's Catalouge locate this resource.
  • A novel combination of cisplatin, irinotecan, and capecitabine in patients with advanced cancer
    Year: 2004
    Journal: Investigational New Drugs
    Volume: 22
    Page numbers: 185-192
    Publisher: Kluwer Academic Publishers
    Author(s):
    Super Search Source this item in the University's Catalouge locate this resource.
  • A phase II study of escalated-dose docetaxel with granulocyte colony-stimulating factor support in patients with advanced breast cancer
    Year: 2004
    Journal: Annals of Oncology
    Volume: 15
    Page numbers: 585-589
    Publisher: Kluwer Academic Publishers(Dordrecht)
    Author(s):
    Super Search Source this item in the University's Catalouge locate this resource.
  • A robust human T-cell culture method suitable for monitoring CD8+ and CD4+ t-cell responses from cancer clinical trial samples
    Year: 2004
    Journal: Journal of Immunological Methods
    Volume: 291
    Page numbers: 51-62
    Publisher: Elsevier Science(Amsterdam)
    Author(s):
    Super Search Source this item in the University's Catalouge locate this resource.
  • Immunodominant CD4+ responses identified in a patient vaccinated with full-length NY-ESO-1 formulated with ISCOMATRIX adjuvant
    Year: 2004
    Journal: Proceedings of the National Academy of Sciences of the United States of America
    Volume: 101
    Issue: 25
    Page numbers: 9363-9368
    Publisher: National Academy of Sciences(Washington DC)
    Author(s):
    Super Search Source this item in the University's Catalouge locate this resource.
  • Metastatic basal cell carcinoma: rapid symptomatic response to cisplatin and paclitaxel
    Year: 2004
    Journal: Australian and New Zealand Journal of Surgery
    Volume: 74
    Page numbers: 704-705
    Publisher: Blackwell Science Asia(Carlton)
    Author(s):
    Super Search Source this item in the University's Catalouge locate this resource.
  • Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4+ and CD8+ T cell responses in humans
    Year: 2004
    Journal: Proceedings of the National Academy of Sciences of the United States of America
    Volume: 101
    Issue: 29
    Page numbers: 10697-10702
    Publisher: National Academy of Sciences(Washington DC)
    Author(s):
    Super Search Source this item in the University's Catalouge locate this resource.
  • The impact of imiquimod, a Toll-like receptor-7 ligand (TLR7L), on the immunogenicity of melanoma peptide vaccination with adjuvant Flt3 ligand
    Year: 2004
    Journal: Cancer Immunity
    Volume: 4
    Issue: 23 September
    Page numbers: 9-19
    Publisher: Academy of Cancer Immunology
    Author(s):
    Super Search Source this item in the University's Catalouge locate this resource.
top of page